World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
20508
World Ranking
16301
National Ranking
8197

Todd A. Alonzo publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Todd A. Alonzo sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 538 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Todd A. Alonzo D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Todd A. Alonzo sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2018 - Fellow of the American Statistical Association (ASA)

Overview

Todd A. Alonzo is affiliated with the University of Southern California in the United States. Their research primarily focuses on hematology, molecular biology, and oncology, with significant contributions to the study of acute myeloid leukemia (AML) and related fields.

The main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields of particular interest are:

  • Hematology
  • Molecular Biology
  • Public Health, Environmental and Occupational Health
  • Oncology
  • Pulmonary and Respiratory Medicine

Major research topics covered by their work include:

  • Acute Myeloid Leukemia Research
  • Protein Degradation and Inhibitors
  • Acute Lymphoblastic Leukemia research
  • Histone Deacetylase Inhibitors Research
  • Neutropenia and Cancer Infections
  • Epigenetics and DNA Methylation
  • Cancer Genomics and Diagnostics

Todd A. Alonzo's publication record features a number of recent papers, including:

  • Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group, 2020, Haematologica
  • CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group, 2021, Blood
  • Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531, 2021, Journal of Clinical Oncology
  • Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia, 2022, Blood Cancer Discovery
  • Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia, 2021, JAMA Oncology

The most frequent co-authors collaborating with Todd A. Alonzo include:

  • Richard Aplenc
  • E. Anders Kolb
  • Soheil Meshinchi
  • Alan S. Gamis
  • Robert B. Gerbing

The venues where they often publish their work are:

  • Blood
  • Journal of Clinical Oncology
  • Blood Advances
  • Pediatric Blood & Cancer
  • Haematologica

Todd A. Alonzo was awarded the title of Fellow of the American Statistical Association (ASA) in 2018.

Best Publications

  • The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions

    Hamid Bolouri;Jason E Farrar;Timothy Triche;Rhonda E Ries

  • Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531

    Alan S. Gamis;Todd A. Alonzo;Soheil Meshinchi;Lillian Sung

  • Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

    Brian V. Balgobind;Susana C. Raimondi;Susana C. Raimondi;Jochen Harbott;Martin Zimmermann

  • Clinical implications of FLT3 mutations in pediatric AML

    Soheil Meshinchi;Todd A. Alonzo;Derek L. Stirewalt;Michel Zwaan

  • Outcomes in CCG-2961, a Children's Oncology Group Phase 3 Trial for untreated pediatric acute myeloid leukemia: a report from the Children's Oncology Group

    Beverly J. Lange;Franklin O. Smith;James Feusner;Dorothy R. Barnard

  • Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.

    Michael R. Loken;Todd A. Alonzo;Todd A. Alonzo;Laura Pardo;Robert B. Gerbing

  • Using a combination of reference tests to assess the accuracy of a new diagnostic test

    Todd A. Alonzo;Margaret S. Pepe

  • Mortality in overweight and underweight children with acute myeloid leukemia.

    Beverly J. Lange;Robert B. Gerbing;James Feusner;Jeffrey Skolnik

  • The genomic landscape of juvenile myelomonocytic leukemia.

    Elliot Stieglitz;Amaro N. Taylor-Weiner;Tiffany Y. Chang;Laura C. Gelston

  • Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor

    Michele S. Redell;Marcos J. Ruiz;Todd A. Alonzo;Todd A. Alonzo;Robert B. Gerbing

  • Distribution-free ROC analysis using binary regression techniques.

    Todd A. Alonzo;Margaret Sullivan Pepe

  • Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: A report from the Children's Oncology Group Study A2971

    Alan S. Gamis;Todd A. Alonzo;Robert B. Gerbing;Joanne M. Hilden

  • AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group.

    Todd M. Cooper;Janet Franklin;Robert B. Gerbing;Todd A. Alonzo

  • The incidence and clinical significance of nucleophosmin mutations in childhood AML

    Patrick Brown;Patrick Brown;Emily McIntyre;Rachel Rau;Soheil Meshinchi;Soheil Meshinchi

  • Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.

    Eric L. Sievers;Beverly J. Lange;Todd A. Alonzo;Robert B. Gerbing

  • Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia

    Lillian Sung;Beverly J. Lange;Robert B. Gerbing;Todd A. Alonzo;Todd A. Alonzo

  • DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update

    Paul P Anglim;Todd A Alonzo;Ite A Laird-Offringa

  • Increased Age at Diagnosis Has a Significantly Negative Effect on Outcome in Children With Down Syndrome and Acute Myeloid Leukemia: A Report From the Children’s Cancer Group Study 2891

    Alan S. Gamis;William G. Woods;Todd A. Alonzo;Allen Buxton

  • Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: A report from the Children's Cancer Group

    Kathryn E. Dusenbery;William B. Howells;Diane C. Arthur;Todd Alonzo

  • Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating By Ewout W. Steyerberg

    Todd A. Alonzo

Frequent Co-Authors

Susana C. Raimondi
Susana C. Raimondi St. Jude Children's Research Hospital
Betsy A. Hirsch
Betsy A. Hirsch University of Minnesota
Beverly J. Lange
Beverly J. Lange Children's Hospital of Philadelphia
Lillian Sung
Lillian Sung University of Toronto
Michael R. Loken
Michael R. Loken Fred Hutchinson Cancer Research Center
William G. Woods
William G. Woods Emory University
Irwin D. Bernstein
Irwin D. Bernstein Fred Hutchinson Cancer Research Center
Nyla A. Heerema
Nyla A. Heerema The Ohio State University
Jerald P. Radich
Jerald P. Radich Fred Hutchinson Cancer Research Center
Stella M. Davies
Stella M. Davies Cincinnati Children's Hospital Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those considering alternative or supplementary paths in healthcare, there are several flexible and affordable online degree options to explore. If you’re concerned about education costs, comparing how much is online nursing school can help you plan your budget and make an informed decision about where to enroll.

Registered Nurses (RNs) looking to advance their qualifications may benefit from rn to bsn online programs, which provide greater flexibility for working professionals. If you aspire to take on leadership or academic roles, earning a phd in nursing can open doors to research and teaching positions at universities.

For those from non-nursing backgrounds who want to transition into the nursing field quickly, direct entry online msn programs offer a fast-track pathway to becoming a registered nurse and earning an advanced degree simultaneously. These online options make it easier than ever to tailor your education and career path to your schedule, goals, and resources.

Best Scientists Citing Todd A. Alonzo

Trending Scientists

Recently Published Articles